DrugsControl Media Services

News Detail

Thermostable TB Vaccine Found Safe and Immunogenic in Humans (08-03-2023)

Washington, 7 March 2023: The Access to Advanced Health Institute (AAHI) published the results of a Phase I clinical trial demonstrating the safety and immunogenicity of a new, thermostable vaccine against tuberculosis (TB), the world’s second deadliest infectious disease. ......
View Details

Source : Genetic Engineering and Biotechnology News
vaccine candidate Vaccine tuberculosis clinical trials

Related News